NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
REGN could head north of 400 post earnings, time to get in is between now @ 358.50 and a low of around 320

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.